You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A prospective study used droplet digital PCR to search for treatment-informative EGFR and KRAS mutations in cell-free DNA from non-small cell lung cancer patients.
Bio-Rad reported $570.6 million in revenues in Q4, a 5 percent drop year over year but a 3 percent increase on a currency-neutral basis.
The consortium will analyze data from patients and mouse models in the first year as part of efforts to find ways of detecting tumors earlier.
Spokespersons from Bio-Rad noted that there appears to be an increasing number of researchers using ddPCR for methylation analyses.
The developers of the method are now using the ddPCR approach to create and test assays for early colon cancer detection.
Bio-Rad scientist Jennifer Berman explains how ddPCR can help detect the basic efficiency of CRISPR/Cas9 and other genome editing technologies and more.
The researchers' proof-of-concept paper published in PLOS One demonstrated a method that could lead to more haplotype analysis in genomic studies of diseases.
The agreements are to distribute RainDance's products in Central and Eastern Europe, Italy, Switzerland, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.
The goal is to design personalized noninvasive ddPCR-based panels to monitor ctDNA levels throughout a patient's disease.
The research may prove relevant to understanding human diversity as well as the genetic underpinning of certain CNV-related disorders.
The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.
According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.
The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.
In Nature this week: the largest known collection of human genetic variants, and more.